---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-036834"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:22:42.530484+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DarioHealth enters $20M at-the-market equity distribution agreement with A.G.P./Alliance Global Partners

## Summary
- Company may issue and sell up to $20M of common stock through ATM program with A.G.P./Alliance Global Partners.
- Commission of 3.00% of gross proceeds; reimbursement of expenses up to $35,000 plus quarterly fees.
- Proceeds to be used for commercial activities, R&D, M&A, corporate activities, repayment of debt, and working capital.
- Shares offered under effective S-3 registration statement filed March 19, 2026, effective March 27, 2026.
- Company has no obligation to sell any shares and may suspend or terminate the agreement at any time.

## SEC filing metadata
- accession: 0001104659-26-036834
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/0001104659-26-036834-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/tm2610107d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-036834
- JSON: https://secwatch.observer/filing/0001104659-26-036834.json
- Plain text: https://secwatch.observer/filing/0001104659-26-036834.txt

## Key facts
- Material Agreements
  DarioHealth Corp. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at $20,000,000 (effective 2026-03-30).
  - Action: entry
  - Agreement: atm program
  - Counterparty: A.G.P./Alliance Global Partners
  - Value: $20,000,000
  - Effective: 2026-03-30
  source text: On March 30, 2026, DarioHealth Corp., a Delaware corporation (the “Company”), entered into a sales agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Agent”), pursuant to which the Company may issue and sell, from time to time, up to an aggregate of $20,000,000 of shares of its common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/0001104659-26-036834-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.